GLAS
A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Subjects with Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis
- Sex at Birth: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase IV
- Conditions Being Studied:
Study Purpose
This study is being done to learn more about the good or bad effects of avacopan and how well it is working in treatment of ANCA-associated vasculitis. Additionally, the study also aims to assess the maintenance of remission (recovery state) on treatment with avacopan in participants confirmed with ANCA-associated vasculitis.
Who Can Participate
Age: 18 and older
Locations
UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106
- UH IRB: STUDY20231420
- StudyID: 2023-01359
- ClinicalTrials.gov: NCT06072482
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422